Back to search
Cancer-related Venous Thromboembolism
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cancer-related Venous Thromboembolism trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Cancer-related Venous Thromboembolism trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Venous thromboembolic disease (VTE) is a common (1/1000), potentially serious disease (10% mortality when the clinical presentation is that of pulmonary embolis…
The goal of this research study is to learn about the quality of life, experiences with treatment, and healthcare costs of patients who are receiving long-term…
This trial seeks to evaluate a management strategy after the acute treatment duration (≥ 3 months of therapeutic anticoagulation) for patients with cancer and c…
The objective of this study is to prospectively develop a risk assessment model (RAM) that accurately identifies anticoagulated cancer-associated thrombosis (CA…
The purpose of this study is to help find how safe current practices are when managing blood thinners in people with cancer who are having surgery or medical pr…
This randomized phase III trial studies the best dose of apixaban and how well it works in preventing secondary cancer related venous thrombosis in cancer patie…